MS
Madden Securities’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,200
| Closed | -$591K | – | 119 |
|
|
2024
Q4 | $591K | Sell |
3,200
-2,630
| -45% | -$485K | 0.24% | 75 |
|
|
2024
Q3 | $1.15M | Sell |
5,830
-8,625
| -60% | -$1.7M | 0.5% | 50 |
|
|
2024
Q2 | $2.99M | Sell |
14,455
-1,225
| -8% | -$253K | 1.32% | 21 |
|
|
2024
Q1 | $4.25M | Sell |
15,680
-770
| -5% | -$209K | 1.96% | 17 |
|
|
2023
Q4 | $3.89M | Sell |
16,450
-2,342
| -12% | -$554K | 2.06% | 15 |
|
|
2023
Q3 | $3.68M | Sell |
18,792
-818
| -4% | -$160K | 2.08% | 15 |
|
|
2023
Q2 | $4.12M | Sell |
19,610
-1,141
| -5% | -$240K | 2.11% | 18 |
|
|
2023
Q1 | $4.19M | Buy |
20,751
+1,670
| +9% | +$337K | 2.22% | 17 |
|
|
2022
Q4 | $4.16M | Buy |
19,081
+3,140
| +20% | +$684K | 2.19% | 13 |
|
|
2022
Q3 | $3.14M | Buy |
15,941
+1,902
| +14% | +$374K | 1.9% | 17 |
|
|
2022
Q2 | $3M | Buy |
14,039
+5,729
| +69% | +$1.23M | 1.65% | 21 |
|
|
2022
Q1 | $2.36M | Buy |
8,310
+5,440
| +190% | +$1.54M | 1.06% | 27 |
|
|
2021
Q4 | $1.08M | Sell |
2,870
-40
| -1% | -$15.1K | 0.51% | 54 |
|
|
2021
Q3 | $1.2M | Sell |
2,910
-3,085
| -51% | -$1.27M | 0.65% | 48 |
|
|
2021
Q2 | $2.22M | Sell |
5,995
-200
| -3% | -$74K | 1.16% | 27 |
|
|
2021
Q1 | $1.8M | Sell |
6,195
-25
| -0.4% | -$7.24K | 1.05% | 30 |
|
|
2020
Q4 | $1.55M | Sell |
6,220
-65
| -1% | -$16.2K | 1% | 34 |
|
|
2020
Q3 | $1.42M | Buy |
6,285
+2,775
| +79% | +$628K | 1.06% | 27 |
|
|
2020
Q2 | $612K | Buy |
+3,510
| New | +$612K | 0.55% | 51 |
|
|
2019
Q4 | $460K | Buy |
+3,012
| New | +$460K | 0.46% | 63 |
|